about
The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavengingTargeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.Anti-inflammatory liposomes have no impact on liver regeneration in ratsObesity alters adipose tissue macrophage iron content and tissue iron distribution.CD163 and inflammation: biological, diagnostic, and therapeutic aspects.Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model.The Staphylococcus aureus Protein IsdH Inhibits Host Hemoglobin Scavenging to Promote Heme Acquisition by the Pathogen.Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of 'soluble CD163' in plasmaAntibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption.Targeting dexamethasone to macrophages in a porcine endotoxemic model.A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis.Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cellsStructural assembly of the megadalton-sized receptor for intestinal vitamin B uptake and kidney protein reabsorptionEfficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriolSTAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomesSpecific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regressionTissue-resident macrophages in omentum promote metastatic spread of ovarian cancerMembrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor ProgressionThe macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms
P50
Q26864505-A6875C8E-71A0-4DDE-AFF0-E1FE74DD112DQ36142511-FCB52DCE-C257-427D-96F3-AA9CA3B93DC3Q36387936-50D81492-A116-4747-917D-589C6BA217DAQ37510168-8F4C494C-D291-4B66-9067-2F13B80E421DQ38035395-2D594038-3693-4790-998F-01D8BFFDE9E2Q39412033-F662581B-0CDC-41E5-BAE9-17F7764BE19DQ40524327-76967A37-6B94-4B02-B622-2F50DEC411FFQ41863389-6392261E-56F1-4FEE-8FA7-7F729203FE1DQ42275739-670ED6CB-219C-41EF-94E5-9C0387A497FDQ42284206-FFA93EDA-89DE-4062-8FA8-DF3959F98DC0Q42921094-FDCBA317-84FA-4EF1-BAD9-3700AA4F148FQ47387140-A8BF3368-4186-4EC8-8E21-71BE2C6DB4F6Q47824054-FF5CA064-BF81-4B85-9A72-742E5A83F414Q51689120-56FC94C3-F0C3-42F8-A27D-A386A3CEABEFQ51768718-9A8C6332-FBB1-49FB-ACDA-61C34920EF0FQ59468768-63E8F7A5-6F52-47D6-95CD-E8FACEA77FD6Q59791297-852554A4-D8D7-4253-9BA7-5BAE389D5203Q60405455-5864C268-E0DA-47F8-8C78-BD3795C49A16Q64097117-13FB90CA-1451-471F-AB7B-7FD27954B75EQ91021394-92FD8CA9-96E2-40C4-8B35-76D3C513FB45Q92376163-4D0D4A2E-F4EE-4E90-9A39-4A742B0D4CDCQ92727192-1F7ACF3F-5DDD-46A3-9C21-34EA32D899DDQ92728069-78F20693-7E0E-47B6-BB83-8DB373108018Q93047114-BA4F7012-2357-4CDA-BADF-CF8E3F777DB1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anders Etzerodt
@ast
Anders Etzerodt
@en
Anders Etzerodt
@es
Anders Etzerodt
@nl
type
label
Anders Etzerodt
@ast
Anders Etzerodt
@en
Anders Etzerodt
@es
Anders Etzerodt
@nl
prefLabel
Anders Etzerodt
@ast
Anders Etzerodt
@en
Anders Etzerodt
@es
Anders Etzerodt
@nl
P1053
E-2839-2013
P106
P1153
36659315000
P21
P31
P3829
P496
0000-0002-6757-2068